Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Kathryn M. Edwards, MD

Professor of Pediatrics Emerita
Vanderbilt University Medical Center
Nashville, TN, United States

Kathryn M. Edwards, MD, Professor of Pediatrics Emerita at Vanderbilt University in Nashville, TN, has led many of the pivotal clinical trials of vaccines licensed in the past several decades and has played a major role in their implementation. She graduated from the University of Iowa College of Medicine and completed her pediatric residency and infectious disease fellowship at Northwestern University and her postdoctoral training in Immunology at Rush Medical School in Chicago, Illinois. Dr. Edwards joined the Vanderbilt Vaccine Program in 1980. She has served on multiple CDC, NIH, FDA, WHO, and IDSA committees. She was the Chair of the Vaccines and Related Biologic Products Advisory Committee of the FDA and has served and continues to serve on multiple vaccine safety and monitoring committees for industry and government. She directed the NIH-funded Vaccine Treatment and Evaluation Unit at Vanderbilt for many years. In 2006, she received the IDSA Mentor Award for her exceptional mentoring and in 2014 received the Maureen Andrews Mentoring Award from the Society for Pediatric Research. In 2008 she was elected to the Institute of Medicine of the National Academy of Sciences, in 2018 she was awarded the Maxwell Finland award for Scientific Accomplishments, in 2019 she received the Frank Morriss Leadership Award in Pediatrics, and in 2020 she was awarded the Howland Award for her accomplishments in Pediatrics by the American Pediatric Society. She is currently active in assessing the safety and effectiveness of vaccines and monoclonal antibodies and in mentoring the next generation of vaccine scientists.


Disclosure(s): Bionet: Advisor/Consultant (Terminated); CSL Seqirus: Data Monitoring Committee (Ongoing); Dynavax: Advisor/Consultant (Ongoing); F. Hoffmann-La Roche Ltd.: Data Monitoring Committee (Ongoing); GlaxoSmithKline Biologicals: Advisor/Consultant (Ongoing); Merck and Company, Inc.: Data Monitoring Committee (Ongoing); Moderna, Inc.: Data Monitoring Committee (Ongoing); Novartis International AG: Data Monitoring Committee (Ongoing); Pfizer, Inc.: Data Monitoring Committee (Ongoing); Sanofi Pasteur LLC: Data Monitoring Committee (Ongoing); X-4 Pharma: Adjudication Committee (Ongoing)

Presentation(s):